362 related articles for article (PubMed ID: 17602084)
21. Laparotomy for post chemotherapy residue in ovarian germ cell tumors.
Mathew GK; Singh SS; Swaminathan RG; Tenali SG
J Postgrad Med; 2006; 52(4):262-5. PubMed ID: 17102543
[TBL] [Abstract][Full Text] [Related]
22. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
23. The quality of life and hormonal disturbances in testicular cancer survivors in Cisplatin era.
Wiechno P; Demkow T; Kubiak K; Sadowska M; Kamińska J
Eur Urol; 2007 Nov; 52(5):1448-54. PubMed ID: 17544206
[TBL] [Abstract][Full Text] [Related]
24. A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach.
Liavaag AH; Dørum A; Bjøro T; Oksefjell H; Fosså SD; Tropé C; Dahl AA
Gynecol Oncol; 2008 Feb; 108(2):348-54. PubMed ID: 17996925
[TBL] [Abstract][Full Text] [Related]
25. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.
Weinberg LE; Lurain JR; Singh DK; Schink JC
Gynecol Oncol; 2011 May; 121(2):285-9. PubMed ID: 21256579
[TBL] [Abstract][Full Text] [Related]
26. Fertility-sparing surgery for malignancies in women.
Gershenson DM
J Natl Cancer Inst Monogr; 2005; (34):43-7. PubMed ID: 15784822
[TBL] [Abstract][Full Text] [Related]
27. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls.
Syrjala KL; Langer SL; Abrams JR; Storer BE; Martin PJ
J Clin Oncol; 2005 Sep; 23(27):6596-606. PubMed ID: 16170167
[TBL] [Abstract][Full Text] [Related]
28. Study of sexual functioning determinants in breast cancer survivors.
Speer JJ; Hillenberg B; Sugrue DP; Blacker C; Kresge CL; Decker VB; Zakalik D; Decker DA
Breast J; 2005; 11(6):440-7. PubMed ID: 16297089
[TBL] [Abstract][Full Text] [Related]
29. Ovarian cancer: an analysis of forty-four patients at the National Radiotherapy Centre, Accra--Ghana.
Vanderpuye V; Yarney J
West Afr J Med; 2007; 26(2):93-6. PubMed ID: 17939307
[TBL] [Abstract][Full Text] [Related]
30. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population.
Park SY; Bae DS; Nam JH; Park CT; Cho CH; Lee JM; Lee MK; Kim SH; Park SM; Yun YH
Cancer; 2007 Dec; 110(12):2716-25. PubMed ID: 17960806
[TBL] [Abstract][Full Text] [Related]
31. Case-control comparison of quality of life in long-term ovarian germ cell tumor survivors: a gynecologic oncology group study.
Monahan PO; Champion VL; Zhao Q; Miller AM; Gershenson D; Williams SD; Cella D
J Psychosoc Oncol; 2008; 26(3):19-42. PubMed ID: 19042263
[TBL] [Abstract][Full Text] [Related]
32. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
[TBL] [Abstract][Full Text] [Related]
33. Ovarian function and childbearing issues in breast cancer survivors.
Gadducci A; Cosio S; Genazzani AR
Gynecol Endocrinol; 2007 Nov; 23(11):625-31. PubMed ID: 17926162
[TBL] [Abstract][Full Text] [Related]
34. Quality of life in long-term survivors of ovarian germ cell tumors: a Gynecologic Oncology Group study.
Champion V; Williams SD; Miller A; Reuille KM; Wagler-Ziner K; Monahan PO; Zhao Q; Gershenson D; Cella D;
Gynecol Oncol; 2007 Jun; 105(3):687-94. PubMed ID: 17355890
[TBL] [Abstract][Full Text] [Related]
35. Quality of life in long-term cervical cancer survivors.
Wenzel L; DeAlba I; Habbal R; Kluhsman BC; Fairclough D; Krebs LU; Anton-Culver H; Berkowitz R; Aziz N
Gynecol Oncol; 2005 May; 97(2):310-7. PubMed ID: 15863123
[TBL] [Abstract][Full Text] [Related]
36. Cognitive functions in long-term survivors of ovarian cancer.
Correa DD; Zhou Q; Thaler HT; Maziarz M; Hurley K; Hensley ML
Gynecol Oncol; 2010 Nov; 119(2):366-9. PubMed ID: 20630576
[TBL] [Abstract][Full Text] [Related]
37. Conservative treatment of ovarian cancer. Safety, ovarian function preservation, reproductive ability, and emotional attitude of the patients in Saudi Arabia.
Sait KH
Saudi Med J; 2011 Sep; 32(9):913-8. PubMed ID: 21894353
[TBL] [Abstract][Full Text] [Related]
38. Conservative surgery in patients with malignant ovarian germ cell tumours.
Al-Sayed MM; El-Sayed AA; El-Barbary TM; Hamad O
J Egypt Soc Parasitol; 2011 Dec; 41(3):737-44. PubMed ID: 22435165
[TBL] [Abstract][Full Text] [Related]
39. Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists.
Calhoun EA; Bennett CL; Peeples PA; Lurain JR; Roland PY; Weinstein JM; Fishman DA
Gynecol Oncol; 1998 Dec; 71(3):369-75. PubMed ID: 9887233
[TBL] [Abstract][Full Text] [Related]
40. Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients.
Schroder M; Mell LK; Hurteau JA; Collins YC; Rotmensch J; Waggoner SE; Yamada SD; Small W; Mundt AJ
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1078-86. PubMed ID: 15752887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
